Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
Agarwal
R
R
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D002216:Captopril / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D007668:Kidney / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D065168:Bradykinin Receptor Antagonists; D000804:Angiotensin II; C065679:icatibant; D002216:Captopril; D001920:Bradykinin